Impact of medical data protection on drug expenditure and accessibility in China

Chinese Journal of New Drugs

Volumn 21, Issue 20, 2012, Pages 2353-2355

  Wu, Suo Wei ^a   Han, Sheng ^a   Chen, Jing ^a,b   Shi, Lu Wen ^a,b  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

Author keywords

Accessibility; Data protection; Expenditure; Generic drug; Innovative drug

Indexed keywords

ARTICLE; CHINA; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; HEALTH CARE ACCESS; HEALTH CARE POLICY; MEDICAL INFORMATICS; QUANTITATIVE ANALYSIS;

EID: 84869132644     PISSN: 10033734     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. 2002.
2. 2005.
3. 2009, 18(19): 1823-1830.
4. AKALEEPHAN C, WIBULPOOPRASERT S, SAKULBUMRUNGSIL R. Extension of market exclusivity and its impact on the accessibility to essential medicines, and drug expense in Thailand: Analysis of the effect of TRIPs-Plus proposal[J]. Health Policy, 2009, 91(2): 174-182.
5. 2009.